Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study

Serious infection rates were higher, and malignancy rates were numerically higher with tofacitinib vs control. Results should be interpreted cautiously due to imbalanced groups and unmeasured confounders.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology
Published
2025-03-07
DOI
https://doi.org/10.1093/mr/roaf017
Citations
3
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
5.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study

Nobunori Takahashi, Michiaki Takagi, Nami Okamoto, Masayoshi Harigai et al.
3 citations
Modern Rheumatology
Rheumatoid Arthritis Research and Therapies
5.00
article

Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study

Nobunori Takahashi, Michiaki Takagi, Nami Okamoto, Masayoshi Harigai, Yoshiya Tanaka, Tsuneyo Mimori, Yutaka Endo, Toshitaka Hirano, Sakae Tanaka, Naoto Tamura, Hiroaki Matsuno, Naonobu Sugiyama, Syuji Takei, Masataka Kuwana, Yoshinari Takasaki, Tatsuya Atsumi, Shigeki Momohara, Tsutomu Takeuchi, Takao Fujii, Masato Hoshi, Kazuhiko Yamamoto, Atsuo Nakajima, Ayako Nakajima, Miki Tanigawa
article en
3 citations

Abstract

Serious infection rates were higher, and malignancy rates were numerically higher with tofacitinib vs control. Results should be interpreted cautiously due to imbalanced groups and unmeasured confounders.

Modern RheumatologyVol. 35(4)
Kagoshima University (JP), Yamagata University (JP), Aichi Medical University (JP), University of Occupational and Environmental Health Japan (JP), Wakayama Medical University (JP), Keio University (JP), Hokkaido University (JP), Kyoto University (JP), Juntendo University (JP), Osaka Rosai Hospital (JP), Japanese Society for Dialysis Therapy (JP), Institute for Rheumatic Diseases (Japan) (JP), Mie University Hospital (JP), Tokyo Women's Medical University (JP), Hokkaido University Hospital (JP), Pfizer (Japan) (JP), Takeda (France) (FR), Takeda (Japan) (JP), The University of Tokyo (JP), Nippon Medical School (JP), Saitama Medical University (JP)
Openalex Percentile: Top 6%
Rheumatoid Arthritis Research and Therapies
5.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.